Antiproliferative action of pyrrolobenzoxazepine derivatives in cultured cells: absence of correlation with binding to the peripheral-type benzodiazepine binding site.
Three novel peripheral-type benzodiazepine binding site (PBBS) ligands, NF 182, 213 and 262, along with the classically used PBBS ligands, PK 11195 and Ro5-4864, were found to inhibit, at micromolar concentrations and in dose-dependent manner, the proliferation of rat C6 glioma and human 1321N1 astrocytoma, without being cytotoxic. This antiproliferative effect is mediated by arrest in the G1 phase of the cell cycle and does not appear to be mediated by a specific interaction of these ligands with the peripheral-type benzodiazepine binding site.
Zisterer
D M
DM
Department of Biochemistry, Trinity College, Dublin, Ireland.
Hance
N
N
Campiani
G
G
Garofalo
A
A
Nacci
V
V
Williams
D C
DC
D000818:Animals; D001569:Benzodiazepines / Q000378:metabolism*; D001570:Benzodiazepinones / Q000378:metabolism / Q000494:pharmacology; D001665:Binding Sites; D002455:Cell Division / Q000187:drug effects*; D002460:Cell Line; D006801:Humans; D007546:Isoquinolines / Q000378:metabolism / Q000494:pharmacology; D007700:Kinetics; D008024:Ligands; D010077:Oxazepines / Q000378:metabolism* / Q000494:pharmacology*; D051381:Rats
D001570:Benzodiazepinones; D007546:Isoquinolines; D008024:Ligands; D010077:Oxazepines; D001569:Benzodiazepines; C028513:4'-chlorodiazepam; C037850:PK 11195